Cimzia (Certolizumab)

Cimzia (certolizumab) is a biologic medicine that helps the pain and swelling of arthritis. It works by blocking Tumor Necrosis Factor (TNF), a type of signalling protein (called a cytokine), that is involved in systemic inflammation.

Cimzia belongs to a class of similar medications called "Anti-Tumor Necrosis Factor" agents.

Cimzia is used to treat Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Psoriasis, and Crohn's Disease.

Taking Cimzia

Cimzia is available in pre-filled syringes or an autoinjectors and is usually taken once every 2 weeks.

Although some patients can feel better quite quickly in others it can take a little longer. Patients starting Cimizia should continue taking the medication as prescribed.

The manufacturer of Cimzia offers a support program to Canadian patients that are prescribed the medication:

Patient support program enrolment forms

Important Tests and Risks

Science

Safety

Video

Watch Dr. Andy Thompson, a Canadian rheumatologist, introduce Cimzia in a short video:

Drug Identification Number (DIN)

02331675 (Pre-filled Syringe)

02465574 (Autoinjector)